|
Immunotherapy
Citations 301-310 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Immunomodulatory drug costimulates T cells via the B7-CD28 pathway
- Richard LeBlanc, Teru Hideshima, Laurence P. Catley, Reshma Shringarpure, Renate Burger, Nicholas Mitsiades, Constantine Mitsiades, Puneet Cheema, Dharminder Chauhan, Paul G. Richardson, Kenneth C. Anderson, and Nikhil C. Munshi
Blood 2004; 103: 1787-1790.
[Abstract]
[Full text]
[PDF]
Antibody-targeted MHC complex–directed expansion of HIV-1– and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination
- Justin Stebbing, Brian Gazzard, Steve Patterson, Mark Bower, Dhayaneethie Perumal, Mark Nelson, Andrew McMichael, Graham Ogg, Agamemnon Epenetos, Frances Gotch, and Philip Savage
Blood 2004; 103: 1791-1795.
[Abstract]
[Full text]
[PDF]
Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies
- John F. DiJoseph, Douglas C. Armellino, Erwin R. Boghaert, Kiran Khandke, Maureen M. Dougher, Latha Sridharan, Arthur Kunz, Philip R. Hamann, Boris Gorovits, Chandrasekhar Udata, Justin K. Moran, Andrew G. Popplewell, Sue Stephens, Philip Frost, and Nitin K. Damle
Blood 2004; 103: 1807-1814.
[Abstract]
[Full text]
[PDF]
A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients
- Ivan C. Moura, Yves Lepelletier, Bertrand Arnulf, Patrick England, Cedric Baude, Carole Beaumont, Ali Bazarbachi, Marc Benhamou, Renato C. Monteiro, and Olivier Hermine
Blood 2004; 103: 1838-1845.
[Abstract]
[Full text]
[PDF]
Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells
- Andrew P. Mone, Peng Huang, Helene Pelicano, Carolyn M. Cheney, Jennifer M. Green, J. Yun Tso, Amy J. Johnson, Sara Jefferson, Thomas S. Lin, and John C. Byrd
Blood 2004; 103: 1846-1854.
[Abstract]
[Full text]
[PDF]
Pregnancy induces minor histocompatibility antigen–specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy
- Rob M. Verdijk, Antoinette Kloosterman, Jos Pool, Maarten van de Keur, Albert M. I. H. Naipal, Astrid G. S. van Halteren, Anneke Brand, Tuna Mutis, and Els Goulmy
Blood 2004; 103: 1961-1964.
[Abstract]
[Full text]
[PDF]
Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model
- Carolina Berger, C. Anthony Blau, Meei-Li Huang, John D. Iuliucci, David C. Dalgarno, Joëlle Gaschet, Shelly Heimfeld, Tim Clackson, and Stanley R. Riddell
Blood 2004; 103: 1261-1269.
[Abstract]
[Full text]
[PDF]
A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis
- Beatrice Saposnik, Jean-Luc Reny, Pascale Gaussem, Joseph Emmerich, Martine Aiach, and Sophie Gandrille
Blood 2004; 103: 1311-1318.
[Abstract]
[Full text]
[PDF]
A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation
- Elisabetta Zino, Guido Frumento, Sarah Marktel, Maria Pia Sormani, Francesca Ficara, Simona Di Terlizzi, Anna Maria Parodi, Ruhena Sergeant, Miryam Martinetti, Andrea Bontadini, Francesca Bonifazi, Daniela Lisini, Benedetta Mazzi, Silvano Rossini, Paolo Servida, Fabio Ciceri, Chiara Bonini, Edoardo Lanino, Giuseppe Bandini, Franco Locatelli, Jane Apperley, Andrea Bacigalupo, Giovanni Battista Ferrara, Claudio Bordignon, and Katharina Fleischhauer
Blood 2004; 103: 1417-1424.
[Abstract]
[Full text]
[PDF]
Fc RIIIa and FcRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia
- Sherif S. Farag, Ian W. Flinn, Rama Modali, Teresa A. Lehman, Donn Young, and John C. Byrd
Blood 2004; 103: 1472-1474.
[Abstract]
[Full text]
[PDF]
|
|
